Under the law allowing pharmacies to dispense naloxone in the state, there is a requirement that the information about the naloxone prescription must be reported to the state’s prescription drug monitoring program, just as pharmacies do with all controlled substances prescriptions. Concern has been expressed to the Board of Pharmacy by the Health Care Authority that pharmacies are not in compliance with this reporting requirement. Subsequently, the Board sent a reminder to pharmacies.
Also in Oregon…The first meeting of the Rules Advisory Committee to discuss proposed rules that would require all supervisors of Oregon pharmacists-in-charge (PICs) to be Oregon-licensed pharmacists and would give PICs carte blanch over the pharmacy operations without regard to company policy will be held Thursday, May 24 at the Board of Pharmacy’s office in Portland. The public is welcome to attend.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.